Cancer Institute
855-776-4224
Call the Mass General Brigham Cancer Institute at 855-776-4224
Expert cancer care, delivered by one team
Learn more about the institute
What sets our cancer care apart
Detecting cancer in its early stages offers more treatment options, helping to lead better outcomes. Our teams focus on identifying cancer as early as possible through risk assessment, advanced imaging, and specialized diagnostic programs. We develop and use screening tools and technologies to support earlier detection and more accurate diagnosis.
At Mass General Brigham, ranked #1 in hospital medical research in the U.S., research is closely integrated into patient care, helping bring new treatments and technologies to patients sooner. We provide access to advanced treatments, technologies, and specialized surgical care that may not be widely available, such as:
- Proton therapy is offered at Massachusetts General Hospital, the only proton therapy site in New England
- Immunotherapy, including CAR T-cell therapy and TIL
- Early-phase clinical trials of novel targeted therapies
These options are supported by close collaboration between researchers and clinicians, helping bring new diagnostics and treatments into care.
At the Cancer Institute, we believe in treating more than just cancer—we care for the patient with cancer. We bring care, research, and expertise together in a coordinated way.
Our approach addresses every aspect of a person’s health, bringing specialists from across medicine together as one team. Patients benefit from specialists working together to align care, consider multiple treatment options, and provide them with access to advanced therapies and clinical trials.
900+
researchers engaged in cancer research
2x
as many cancer surgeries as any other health system in Massachusetts
No. 1
recipient of NIH funding in New England, with more than $456 million in annual research funding
1,000+
active clinical trials per year
Patient story
Innovative test and treatment result in world-class care for brain tumor
Read Rohan's story
Explore all patient stories
New era of excellence in cancer care and research
Cancer conditions we treat
- Acute Myeloid Leukemia (AML)
- ALK Lung Cancer
- Anal Cancer
- Bile Duct Cancer
- Bladder Cancer
- Acute Lymphocytic Leukemia
- Cervical Cancer
- Chordoma
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Endometrial Cancer
- Esophageal Cancer
- Ewing Sarcoma
- Gallbladder Cancer
- Gastrointestinal Stromal Tumor (GIST)
- Kidney Cancer
- Laryngeal Cancer
- Leukemia
- Medulloblastoma
- Merkel Cell Cancer
- Multiple Myeloma
- Oral Cancer
- Ovarian Cancer
- Prostate Cancer
- Rhabdomyosarcoma
- Spinal Cord Tumor
- Stomach Cancer
- Testicular Cancer
- Breast Cancer
- Pancreatic Cancer
- Colorectal Cancer
- Lung Cancer
- Lymphoma
- Pituitary Tumors
- Melanoma
- Head and Neck Cancer
- Liver Cancer
- Blood Cancer
- Radiation Therapy
- Bone Marrow Transplant
- CAR T-Cell Therapy
- Brachytherapy
- Hepatic Artery Infusion Pump
- Lumpectomy
- Mastectomy
- Proton Therapy
- Tumor-Infiltrating Lymphocytes Therapy
- Whipple Procedure
- Brain Cancer Treatment
- Chemotherapy
- Intensity-Modulated Radiation Therapy (IMRT)
- Hormone Therapy
Our cancer specialists
Cancer care near you
See all locations
Cancer research at Mass General Brigham
Advancing cancer care through research
Explore Cancer Institute research
Learn how cancer research informs patient care
Find clinical trials
Search open cancer clinical trials and studies
Giving to the Cancer Institute
Patient resources and support
View all patient resources
Contact the Cancer Institute
855-776-4224
Call the Cancer Institute at 855-776-4224
International Patient Services
Contact information for international patients